Follicular fluid-derived exosomal miR-143-3p/miR-155-5p regulate follicular dysplasia by modulating glycolysis in granulosa cells in polycystic ovary syndrome. 2022

Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
Guangxi Key Laboratory of Environmental Exposomics and Entire Lifecycle Health, Guilin Medical University, Guilin, 541199, China.

Polycystic ovary syndrome (PCOS) is characterized by follicular dysplasia. An insufficient glycolysis-derived energy supply of granulosa cells (GCs) is an important cause of follicular dysplasia in PCOS. Follicular fluid (FF) exosomal microRNAs (miRNAs) have been proven to regulate the function of GCs. In this study, exosomes extracted from clinical FF samples were used for transcriptome sequencing (RNA-seq) analysis, and a human ovarian granulocyte tumour cell line (KGN cells) was used for in vitro mechanistic studies. In FF exosomal RNA-seq analysis, a decrease in glycolysis-related pathways was identified as an important feature of the PCOS group, and the differentially expressed miR-143-3p and miR-155-5p may be regulatory factors of glycolysis. By determining the effects of miR-143-3p and miR-155-5p on hexokinase (HK) 2, pyruvate kinase muscle isozyme M2 (PKM2), lactate dehydrogenase A (LDHA), pyruvate, lactate and apoptosis in KGN cells, we found that upregulated miR-143-3p expression in exosomes from the PCOS group inhibited glycolysis in KGN cells; knockdown of miR-143-3p significantly alleviated the decrease in glycolysis in KGN cells in PCOS. MiR-155-5p silencing attenuated glycolytic activation in KGN cells; overexpression of miR-155-5p significantly promoted glycolysis in KGN cells in PCOS. In this study, HK2 was found to be the mediator of miR-143-3p and miR-155-5p in FF-derived exosome-mediated regulation of glycolysis in KGN cells. Reduced glycolysis accelerated apoptosis of KGN cells, which mediated follicular dysplasia through ATP, lactate and apoptotic pathways. In conclusion, these results indicate that miR-143-3p and miR-155-5p in FF-derived exosomes antagonistically regulate glycolytic-mediated follicular dysplasia of GCs in PCOS. Video Abstract.

UI MeSH Term Description Entries
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D005260 Female Females
D006019 Glycolysis A metabolic process that converts GLUCOSE into two molecules of PYRUVIC ACID through a series of enzymatic reactions. Energy generated by this process is conserved in two molecules of ATP. Glycolysis is the universal catabolic pathway for glucose, free glucose, or glucose derived from complex CARBOHYDRATES, such as GLYCOGEN and STARCH. Embden-Meyerhof Pathway,Embden-Meyerhof-Parnas Pathway,Embden Meyerhof Parnas Pathway,Embden Meyerhof Pathway,Embden-Meyerhof Pathways,Pathway, Embden-Meyerhof,Pathway, Embden-Meyerhof-Parnas,Pathways, Embden-Meyerhof
D006107 Granulosa Cells Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH). Cell, Granulosa,Cells, Granulosa,Granulosa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015571 Follicular Fluid The fluid surrounding the OVUM and GRANULOSA CELLS in the Graafian follicle (OVARIAN FOLLICLE). The follicular fluid contains sex steroids, glycoprotein hormones, plasma proteins, mucopolysaccharides, and enzymes. Antral Fluid, Ovarian Follicle,Liquor Folliculi,Fluid, Follicular,Follicular Fluids,Folliculi, Liquor
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D035683 MicroRNAs Small double-stranded, non-protein coding RNAs, 21-25 nucleotides in length generated from single-stranded microRNA gene transcripts by the same RIBONUCLEASE III, Dicer, that produces small interfering RNAs (RNA, SMALL INTERFERING). They become part of the RNA-INDUCED SILENCING COMPLEX and repress the translation (TRANSLATION, GENETIC) of target RNA by binding to homologous 3'UTR region as an imperfect match. The small temporal RNAs (stRNAs), let-7 and lin-4, from C. elegans, are the first 2 miRNAs discovered, and are from a class of miRNAs involved in developmental timing. RNA, Small Temporal,Small Temporal RNA,miRNA,stRNA,Micro RNA,MicroRNA,Primary MicroRNA,Primary miRNA,miRNAs,pre-miRNA,pri-miRNA,MicroRNA, Primary,RNA, Micro,Temporal RNA, Small,miRNA, Primary,pre miRNA,pri miRNA

Related Publications

Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
March 2022, Scientific reports,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
September 2021, Cellular signalling,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
January 2021, Computational and mathematical methods in medicine,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
May 2024, Journal of assisted reproduction and genetics,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
November 2020, Journal of molecular endocrinology,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
April 2022, Molecular neurobiology,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
January 2022, PeerJ,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
December 2019, Artificial cells, nanomedicine, and biotechnology,
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
October 1996, Human reproduction (Oxford, England),
Jianping Cao, and Peng Huo, and Kuiqing Cui, and Huimei Wei, and Junna Cao, and Jinyuan Wang, and Qingyou Liu, and Xiaocan Lei, and Shun Zhang
December 2021, Reproductive toxicology (Elmsford, N.Y.),
Copied contents to your clipboard!